View
234
Download
2
Category
Preview:
Citation preview
49
DAFTAR PUSTAKA
1. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA, Setiyohadi B, Alwi I, et al,
editor. Buku ajar ilmu penyakit dalam jilid I. Edisi keempat. Jakarta: Pusat
Penerbitan Departemen Ilmu Penyakit Dalam FK UI, 2007.
2. Thorn, Adams, Braunwald, Isselbacher, & Petersdorf. Harrison's Principles of
Internal Medicine. Edisi IX. Jakarta Utara: Penerbit Buku Kedokteran; 1991.
3. The Global Burden Of Deseases 2004 [database on the internet]. WHO. 2008
[cited 16 November 2013]. Available from: www.who.int/evidence/bod.
4. Liver cirrhosis mortality rates in Britain from 1950 to 2002 an analysis of
routine data [database on the internet]. Leon,D. 2006 [cited 2 Desember
2013]. Available from: http:// www.thelancet.com.
5. Statistics About Liver of Cirrhosis [database on the internet]. NCHS. 2003
[cited 5 November 2013]. Available from:
http://www.wrongdiagnosis.com/c/cirrhosis_of_the_liver/stats.htm.
6. National Vital Statistics Reports [database on the internet]. Xu dkk. 2010
[cited 16 Desember 2013]. Available from:
http://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm.
7. Muttaqin, A., & Sari, K. Gangguan Gastrointestinal. Jakarta: Penerbit
Salemba Medika; 2011.
8. Farrell, G. C., 2008, Cirrhosis in Asians: Less common than in Europeans
Journal of Gastroenterology and Hepatology, Volume 23, Issue 4, pages 508–
511 http://onlinelibrary.wiley.com/doi.
9. Kusumobroto O Hernomo. Sirosis Hati dalam buku ajar Ilmu Penyakit Hati.
Edisi I. Jakarta: Jayabadi; 2007.
10. Karina. Faktor Risiko Kematian Penderita Sirosis Hati Di RSUP Dr. Kariadi
Semarang Tahun 2002–2006, Jurnal Media Medika Muda [internet]. 2007
[cited 2014 Maret 11]. Available from:
http://eprints.undip.ac.id/view/divisions/sch=5Fmed/2007.html#group_K.
11. Sulaiman A. Gasrtoenterologi Hepatologi. Jakarta: CV. Sagung Seto; 1997.
50
12. Global Burden of Viral Hepatitis [database on the internet]. WHO Geneva.
2010 [cited 12 Desember 2013]. Available from: http://
www.who.int/evidence/bod.
13. Hepatitis B and HIV Coinfecton Clinical Protocol [database on the internet].
WHO European Region. 2010 [cited 16 Desember 2013].
14. Laporan Hasil Riset Kesehatan Dasar RISKESDAS Indonesia [database on
the internet]. Departemen Kesehatan. 2007 [ cited 2 Januari 2014].
15. Profil Kesehatan 2008 [database on the internet]. Departemen Kesehatan.
2009 [cited 2 Januari 2014]. Available from: http//www.depkes.go.id .
16. Setiawati, M. Perbandingan Validitas Maddrey’s Discriminant Function dan
Skor Child-Pugh dalam Memprediksi Ketahanan Hidup 12 Minggu pada
Pasien Sirosis Hepatis. Semarang: Fakultas Kedokteran Universitas
Diponegoro; 2009.
17. Deep vein thrombosis in patient with cirrhosis [database on the internet].
Lesmana, dkk. 2009 [cited 16 Januari 2014]. Available from:
http://www.who.int/research/en.
18. Simamora, C. T. Hubungan Komplikasi, Skor Child-Turcotte dan Usia Lanjut
Sebagai Faktor Resiko Kematian Pada Pasien Sirosis Hati di RSUD Dr.
Soedarso Pontianak. Pontianak; 2013.
19. Malau, A. S. Karakteristik Penderita Sirosis Hati Yang Dirawat Inap Di
Rumah Sakit Martha Friska Medan Tahun 2006-2010. Medan; 2011.
20. Report of The Regional Committee for the Eastern Mediterranean Fifty-sixth
Session Fez, Morocco 5–8 October 2009 [database on the internet]. Mohsni.
2009 [cited 6 Pebruari 2014]. Available from: http://search.who.int/.
21. Statistics by Country for Cirrhosis of the liver [database on the internet]. US
Census Bureau, International Data Base. 2005 [cited 11 Januari 2014].
Available from: http://www.cureresearch.com/c/cirrhosis_of_the_liver/stats-
country_ printer.htm.
22. Ndraha. The Indonesian Journal of Gastroenterology, Hepatology, and
Digestive Endoscopy. Volume 10, Number 3; 2009.
23. Hadi, S. Gastroenterologi. Bandung: Penerbit Alumni Bandung; 2002.
51
24. Liver cirrhosis–Epidemiological and Clinical Aspects Department of Internal
Medicine Sahlgrenska University Hospital, Goteborg University, Sweden
[database on the internet]. Gunnarsdottir. 2008 [cited 3 Pebruari 2014].
Available from: www.gupea.ub.gu.se/bitstream/2077/10132/1/Ramen-Avh-
SAG.pdf.
25. Rasyid. Temuan Ultrasonografi Kanker Hati Hepatoseluler Hepatoma.
Majalah Kedokteran Nusantara. Volume 39 No 2; 2006.
26. Sulaiman A. Harapan Baru Dalam Penatalaksanaan Sirosis Hati, Dalam
Pertemuan Ilmiah Tahunan Perkembangan Muktahir Ilmu Penyakit Dalam.
Jakarta: Balai Penerbit FK UI; 2003.
27. Death Rates [database on the internet]. WHO. 2004 [cited 8 Pebruari 2014].
Available from: http://www.who.int.
28. Studi Penggunaan Obat Pada Pasien Sirosis Hepatik [database on the internet].
Rencianisari. 2008 [cited 4 Pebruari 2014]. Available from:
http://adln.lib.unair.ac.id/go.php?id=gdlhub-gdl-s1-2011-.
29. Percentage of total deaths, death rates, age-adjusted death rates for 2007,
percentage change in age-adjusted death rates in 2007 from 2006, and ratio of
age-adjusted death rates, by race and sex for the 15 leading causes of death
for the total population in 2007 [database on the internet]. National Vital
Statistics Reports. 2010 [cited 15 Pebruari 2014]. Available from:
http://www.cdc.gov/nchs.
30. Avunduk, C. Manual of Gastroenterology Diagnosis and Therapy. Edisi IV.
Philadelphia: Lippincott Williams & Wilkins; 2008.
31. Sherlock S, Dooley J. Disease of the liver and biliary system. Edisi IX.
Oxford: Blackwell Scientific Publications, 1993: 357-67.
32. Rigas B, Spiro HM. Clinical Gastroenterology: companion book. Edisi IV.
New York: Mc Graw Hill, 1995: 588-611.
33. Global Burden of Diseases in 2002 [database on the internet]. WHO Global.
2008 [cited 9 Pebruari 2014]. Available from: http://www.wpro.who.int.
52
34. Arguedes MR, Fallon MB. Cirrhosis of the liver and its complications. In:
Carpenter CCJ, Griggs RC, Loscalzo J, editors. Cecil essentials of medicine.
Edisi XI. Pennsylvania: Saunders, 2004: 411-7.
35. Price S.A. Patofisiologi konsep Klinis Proses-proses Penyakit, Edisi VI.
Jakarta: EGC; 2006.
36. Kayacetin E, Efe D, Dogan C. Portal and splenic hemodynamics in cirrhotic
patients: relationship between esophageal variceal bleeding and the severity
of hepatic failure. Journal of Gastroenterology, 2004; 39: 661-7.
37. Friedman SL, McQuaid KR, Grendell JH. Current diagnosis and treatment in
gastroenterology. 2nd ed. New York: Mc Graw Hill, 2003: 644-62.
38. Porth CM. Pathophysiology: concepts of altered health states. 5th ed.
Philadelphia, 1998: 761-6.
39. Weiss GR. Clinical oncology. Connecticut: Appleton & Lange; 1993.
40. Cardenas A, Arroyo V. Mechanism of water and sodium retension in
cirrhosis and the phatogenesis of ascites. Best Pract Res Clin Endokrinol
Metab 2003; 17: 607-22.
41. Cheney CP, Goldberg EM, Chopra S. Cirrhosis and portal hypertension: an
overview. In: Friedman LS, Keeffe EB, editors. Handbook of liver disease.
2nd ed. China: Churchill Livingstone, 2004: 125-37.
42. Gilroy J. Basic neurology. 3rd ed. New York: Mc Graw Hill, 2000: 517-8.
43. Hassan HA. Spontaneous Bacterial Peritonitis. Dalam: Adi S, editor. Naskah
lengkap pendidikan kedokteran berkelanjutan XVI. Surabaya: Laboratorium
SMF Penyakit Dalam FK Unair RSUD Dr. Sutomo, 2001: 41-59.
44. Hirlan. Nutrisi enteral dan parenteral pada penderita penyakit hati kronik.
Dalam: Soeroso S, Haryoko W, Setiati TE, Kosim HMS, Triwara B, editor.
Gizi klinik: Nutrisi enteral dan parenteral. Badan Penerbit Universitas
Diponegoro; 1994.
45. Doubatty, AC. 2009. Perbandingan validitas skor mayo end stage liver
disease dan skor child-pugh dalam memprediksi ketahanan hidup 12 minggu
pada pasien sirosis hepatis. Semarang: Universitas Diponegoro.
53
46. Shibli, AB; Tachauer, A; Mohanty, SR.; 2006, Outpatient Management of
Cirrhosis, Southern Medicaal Journal, 99 (6), 559-561.
47. Clinical profile of patients with cirrhosis of liver in a tertiary carehospital,
Dharan, Nepal [database on the internet]. Maskey R, Karki P, Ahmed S V,
Manandhar D N. 2011 [cited 3 Maret 2014]. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22364095.
48. Sarin SK, Chari S, Sundaram KR, Ahuja RK, Anand BS, Broor SL. Young
versus adult cirrhosis: a prospective comparative analysis of the clinical
profile, natural course and survival. Gut 1988; 29: 101-7.
49. Etiology of Liver Cirrhosis in Mexico [database on the internet]. Méndez-
Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B,
et al. 2004 [cited 22 Juli 2014]. Available from:
http://new.medigraphic.com/cgibin/resumenMainI.cgi?IDARTICULO=12532.
50. Complications of liver cirrhosis [database on the internet]. Wittenburg H,
Tennert U, Berg T. 2011 [cited 22 Juli 2014]. Available from:
http://europepmc.org/abstract/MED/21611819.
54
Lampiran 1. Analisis Univariat beberapa Variabel
NPar Tests
Statistics
303 245 259 226 303
2 60 46 79 2
54.17 4.4606 2.3448 8.1827 10.46
54.00 1.9800 2.3000 5.3000 9.00
11.755 5.92105 .60094 12.46432 7.626
16 .11 .90 -.90 0
81 36.31 4.66 106.30 48
Valid
Missing
N
Mean
Median
Std. Dev iation
Minimum
Maximum
Usia Bilirubin Total
Albumin
serum PPT
Lama
perawatan
One-Sample Kolmogorov-Smirnov Test
303 245 259 226 303
54.17 4.4606 2.3448 8.1827 10.46
11.755 5.92105 .60094 12.46432 7.626
.062 .231 .064 .239 .145
.062 .221 .064 .232 .145
-.055 -.231 -.040 -.239 -.101
1.080 3.620 1.023 3.589 2.522
.193 .000 .246 .000 .000
N
Mean
Std. Dev iation
Normal Parametersa,b
Absolute
Positive
Negative
Most Extreme
Dif f erences
Kolmogorov-Smirnov Z
Asy mp. Sig. (2-tailed)
Usia Bilirubin Total
Albumin
serum PPT
Lama
perawatan
Test distribution is Normal.a.
Calculated f rom data.b.
55
Frequency Table
Jenis kelamin
205 67,7 67,7 67,7
98 32,3 32,3 100,0
303 100,0 100,0
Laki-laki
Perempuan
Total
Valid
Frequency Percent Valid Percent
Cumulat iv e
Percent
Usia
10 3.3 3.3 3.3
21 6.9 6.9 10.2
79 26.1 26.1 36.3
104 34.3 34.3 70.6
59 19.5 19.5 90.1
30 9.9 9.9 100.0
303 100.0 100.0
< 31
31 - 40
41 - 50
51 - 60
61 - 70
> 70
Total
Valid
Frequency Percent Valid Percent
Cumulat iv e
Percent
HBV
184 60.7 60.7 60.7
119 39.3 39.3 100.0
303 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
HCV
55 18.2 18.2 18.2
248 81.8 81.8 100.0
303 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
56
NAFL
21 6.9 6.9 6.9
282 93.1 93.1 100.0
303 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Alkohol
303 100.0 100.0 100.0TidakValid
Frequency Percent Valid Percent
Cumulativ e
Percent
Lain-lain
59 19.5 19.5 19.5
244 80.5 80.5 100.0
303 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Klasifikasi CHILD-PUGH
15 5,0 6,4 6,4
75 24,8 32,1 38,5
144 47,5 61,5 100,0
234 77,2 100,0
69 22,8
303 100,0
A
B
C
Total
Valid
Sy stemMissing
Total
Frequency Percent Valid Percent
Cumulat iv e
Percent
57
Perdarahan var. Esof
59 19,5 19,5 19,5
244 80,5 80,5 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Ensefalopati Hepatikum
66 21,8 21,8 21,8
237 78,2 78,2 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Karsinoma Hepatoseluler
34 11,2 11,2 11,2
269 88,8 88,8 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Sindr. Hepatorenal
5 1,7 1,7 1,7
298 98,3 98,3 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
58
Hematemesis
79 26,1 26,1 26,1
224 73,9 73,9 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Melena
85 28,1 28,1 28,1
218 71,9 71,9 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Ascites
224 73,9 73,9 73,9
79 26,1 26,1 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Peritonitis bakterial spontan
1 ,3 ,3 ,3
302 99,7 99,7 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Gastropati HT Porta
39 12,9 12,9 12,9
264 87,1 87,1 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
59
Efusi pleura
38 12,5 12,5 12,5
265 87,5 87,5 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Pneumonia
37 12,2 12,2 12,2
266 87,8 87,8 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
TB paru
5 1,7 1,7 1,7
298 98,3 98,3 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Syok
7 2,3 2,3 2,3
296 97,7 97,7 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
60
Sepsis
19 6,3 6,3 6,3
284 93,7 93,7 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Penyakit ginjal
10 3,3 3,3 3,3
293 96,7 96,7 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Penyakit jantung
3 1,0 1,0 1,0
300 99,0 99,0 100,0
303 100,0 100,0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Survival rate
60 19,8 19,8 19,8
243 80,2 80,2 100,0
303 100,0 100,0
Meninggal
Hidup
Total
Valid
Frequency Percent Valid Percent
Cumulat iv e
Percent
Perut membesar
111 36.4 36.4 36.4
194 63.6 63.6 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
61
Nyeri perut
17 5.6 5.6 5.6
288 94.4 94.4 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Berak darah
32 10.5 10.5 10.5
273 89.5 89.5 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Muntah darah
63 20.7 20.7 20.7
242 79.3 79.3 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Badan lemas
15 4.9 4.9 4.9
290 95.1 95.1 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Penurunan kesadaran
18 5.9 5.9 5.9
287 94.1 94.1 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
62
Mata kuning
13 4.3 4.3 4.3
292 95.7 95.7 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Lain2
48 15.7 15.7 15.7
257 84.3 84.3 100.0
305 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulativ e
Percent
Ensefalopati
32 10.5 44.4 44.4
40 13.1 55.6 100.0
72 23.6 100.0
233 76.4
305 100.0
grade I-I I
grade III -IV
Total
Valid
Sy stemMissing
Total
Frequency Percent Valid Percent
Cumulat iv e
Percent
Ascites
180 59.0 80.4 80.4
44 14.4 19.6 100.0
224 73.4 100.0
81 26.6
305 100.0
ringan-sedang
berat
Total
Valid
Sy stemMissing
Total
Frequency Percent Valid Percent
Cumulat iv e
Percent
63
Lampiran 2. Analisis Bivariat beberapa Variabel terhadap Survival Rate
Jenis kelamin * Survival rate Crosstabulation
39 166 205
65,0% 68,3% 67,7%
12,9% 54,8% 67,7%
21 77 98
35,0% 31,7% 32,3%
6,9% 25,4% 32,3%
60 243 303
100,0% 100,0% 100,0%
19,8% 80,2% 100,0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Laki-laki
Perempuan
Jenis kelamin
Total
Meninggal Hidup
Surv ival rate
Total
64
HBV * Survival rate Crosstabulation
35 149 184
58.3% 61.3% 60.7%
11.6% 49.2% 60.7%
25 94 119
41.7% 38.7% 39.3%
8.3% 31.0% 39.3%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Ya
Tidak
HBV
Total
Meninggal Hidup
Surv ival rate
Total
HCV * Survival rate Crosstabulation
8 47 55
13.3% 19.3% 18.2%
2.6% 15.5% 18.2%
52 196 248
86.7% 80.7% 81.8%
17.2% 64.7% 81.8%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Ya
Tidak
HCV
Total
Meninggal Hidup
Surv ival rate
Total
NAFL * Survival rate Crosstabulation
3 18 21
5.0% 7.4% 6.9%
1.0% 5.9% 6.9%
57 225 282
95.0% 92.6% 93.1%
18.8% 74.3% 93.1%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Ya
Tidak
NAFL
Total
Meninggal Hidup
Surv ival rate
Total
65
Alkohol * Survival rate Crosstabulation
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
TidakAlkohol
Total
Meninggal Hidup
Surv ival rate
Total
Lain-lain * Survival rate Crosstabulation
18 41 59
30.0% 16.9% 19.5%
5.9% 13.5% 19.5%
42 202 244
70.0% 83.1% 80.5%
13.9% 66.7% 80.5%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Ya
Tidak
Lain-lain
Total
Meninggal Hidup
Surv iv al rate
Total
66
Klasifikasi CHILD-PUGH * Survival rate Crosstabulation
0 15 15
,0% 8,2% 6,4%
,0% 6,4% 6,4%
4 71 75
7,7% 39,0% 32,1%
1,7% 30,3% 32,1%
48 96 144
92,3% 52,7% 61,5%
20,5% 41,0% 61,5%
52 182 234
100,0% 100,0% 100,0%
22,2% 77,8% 100,0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
A
B
C
Klasif ikasi
CHILD-PUGH
Total
Meninggal Hidup
Surv iv al rate
Total
67
Usia * Survival rate
Crosstab
1 9 10
2.0 8.0 10.0
1.7% 3.7% 3.3%
.3% 3.0% 3.3%
3 18 21
4.2 16.8 21.0
5.0% 7.4% 6.9%
1.0% 5.9% 6.9%
15 64 79
15.6 63.4 79.0
25.0% 26.3% 26.1%
5.0% 21.1% 26.1%
19 85 104
20.6 83.4 104.0
31.7% 35.0% 34.3%
6.3% 28.1% 34.3%
15 44 59
11.7 47.3 59.0
25.0% 18.1% 19.5%
5.0% 14.5% 19.5%
7 23 30
5.9 24.1 30.0
11.7% 9.5% 9.9%
2.3% 7.6% 9.9%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
< 31
31 - 40
41 - 50
51 - 60
61 - 70
> 70
Usia
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
2.604a 5 .761
2.663 5 .752
1.882 1 .170
303
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
2 cells (16.7%) have expected count less than 5. The
minimum expected count is 1.98.
a.
68
Efusi pleura * Survival rate
Crosstab
3 35 38
7.5 30.5 38.0
5.0% 14.4% 12.5%
1.0% 11.6% 12.5%
57 208 265
52.5 212.5 265.0
95.0% 85.6% 87.5%
18.8% 68.6% 87.5%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Ef usi pleura
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
3.879b 1 .049
3.069 1 .080
4.649 1 .031
.051 .032
3.866 1 .049
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 7.
52.
b.
69
Pneumonia * Survival rate
Crosstab
15 22 37
7.3 29.7 37.0
25.0% 9.1% 12.2%
5.0% 7.3% 12.2%
45 221 266
52.7 213.3 266.0
75.0% 90.9% 87.8%
14.9% 72.9% 87.8%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Pneumonia
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
11.414b 1 .001
9.975 1 .002
9.780 1 .002
.002 .002
11.377 1 .001
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 7.
33.
b.
70
TB paru * Survival rate
Crosstab
0 5 5
1.0 4.0 5.0
.0% 2.1% 1.7%
.0% 1.7% 1.7%
60 238 298
59.0 239.0 298.0
100.0% 97.9% 98.3%
19.8% 78.5% 98.3%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
TB paru
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
1.255b 1 .263
.308 1 .579
2.227 1 .136
.587 .329
1.251 1 .263
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
99.
b.
71
Syok * Survival rate
Crosstab
7 0 7
1.4 5.6 7.0
11.7% .0% 2.3%
2.3% .0% 2.3%
53 243 296
58.6 237.4 296.0
88.3% 100.0% 97.7%
17.5% 80.2% 97.7%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Sy ok
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
29.020b 1 .000
24.081 1 .000
23.359 1 .000
.000 .000
28.925 1 .000
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.
39.
b.
72
Sepsis * Survival rate
Crosstab
18 1 19
3.8 15.2 19.0
30.0% .4% 6.3%
5.9% .3% 6.3%
42 242 284
56.2 227.8 284.0
70.0% 99.6% 93.7%
13.9% 79.9% 93.7%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Sepsis
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
71.676b 1 .000
66.730 1 .000
55.730 1 .000
.000 .000
71.439 1 .000
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.
76.
b.
73
Penyakit ginjal * Survival rate
Crosstab
4 6 10
2.0 8.0 10.0
6.7% 2.5% 3.3%
1.3% 2.0% 3.3%
56 237 293
58.0 235.0 293.0
93.3% 97.5% 96.7%
18.5% 78.2% 96.7%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Peny akit
ginjal
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
2.657b 1 .103
1.504 1 .220
2.231 1 .135
.114 .114
2.648 1 .104
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.
98.
b.
74
Penyakit jantung * Survival rate
Crosstab
0 3 3
.6 2.4 3.0
.0% 1.2% 1.0%
.0% 1.0% 1.0%
60 240 300
59.4 240.6 300.0
100.0% 98.8% 99.0%
19.8% 79.2% 99.0%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Peny akit
jantung
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
.748b 1 .387
.019 1 .891
1.331 1 .249
1.000 .515
.746 1 .388
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
59.
b.
75
Perdarahan var. Esof * Survival rate
Crosstab
7 52 59
11.7 47.3 59.0
11.7% 21.4% 19.5%
2.3% 17.2% 19.5%
53 191 244
48.3 195.7 244.0
88.3% 78.6% 80.5%
17.5% 63.0% 80.5%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Perdarahan
var. Esof
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
2.907b 1 .088
2.319 1 .128
3.197 1 .074
.102 .059
2.897 1 .089
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 11.
68.
b.
76
Ensefalopati Hepatikum * Survival rate
Crosstab
41 25 66
13.1 52.9 66.0
68.3% 10.3% 21.8%
13.5% 8.3% 21.8%
19 218 237
46.9 190.1 237.0
31.7% 89.7% 78.2%
6.3% 71.9% 78.2%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Ensef alopati
Hepatikum
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
95.157b 1 .000
91.781 1 .000
81.663 1 .000
.000 .000
94.843 1 .000
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 13.
07.
b.
77
Karsinoma Hepatoseluler * Survival rate
Crosstab
5 29 34
6.7 27.3 34.0
8.3% 11.9% 11.2%
1.7% 9.6% 11.2%
55 214 269
53.3 215.7 269.0
91.7% 88.1% 88.8%
18.2% 70.6% 88.8%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Karsinoma Hepatoseluler
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
.626b 1 .429
.317 1 .573
.668 1 .414
.502 .296
.624 1 .429
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 6.
73.
b.
78
Sindr. Hepatorenal * Survival rate
Crosstab
2 3 5
1.0 4.0 5.0
3.3% 1.2% 1.7%
.7% 1.0% 1.7%
58 240 298
59.0 239.0 298.0
96.7% 98.8% 98.3%
19.1% 79.2% 98.3%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Sindr. Hepatorenal
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
1.306b 1 .253
.333 1 .564
1.093 1 .296
.258 .258
1.302 1 .254
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
99.
b.
79
Hematemesis * Survival rate
Crosstab
17 62 79
15.6 63.4 79.0
28.3% 25.5% 26.1%
5.6% 20.5% 26.1%
43 181 224
44.4 179.6 224.0
71.7% 74.5% 73.9%
14.2% 59.7% 73.9%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Hematemesis
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
.198b 1 .656
.079 1 .779
.196 1 .658
.743 .384
.198 1 .657
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 15.
64.
b.
80
Melena * Survival rate
Crosstab
18 67 85
16.8 68.2 85.0
30.0% 27.6% 28.1%
5.9% 22.1% 28.1%
42 176 218
43.2 174.8 218.0
70.0% 72.4% 71.9%
13.9% 58.1% 71.9%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Melena
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
.141b 1 .708
.046 1 .830
.139 1 .709
.749 .410
.140 1 .708
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 16.
83.
b.
81
Ascites * Survival rate
Crosstab
47 177 224
44.4 179.6 224.0
78.3% 72.8% 73.9%
15.5% 58.4% 73.9%
13 66 79
15.6 63.4 79.0
21.7% 27.2% 26.1%
4.3% 21.8% 26.1%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Ascites
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
.753b 1 .385
.495 1 .482
.777 1 .378
.417 .243
.751 1 .386
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 15.
64.
b.
82
Peritonitis bakterial spontan * Survival rate
Crosstab
1 0 1
.2 .8 1.0
1.7% .0% .3%
.3% .0% .3%
59 243 302
59.8 242.2 302.0
98.3% 100.0% 99.7%
19.5% 80.2% 99.7%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Peritonitis bakterial
spontan
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
4.063b 1 .044
.576 1 .448
3.252 1 .071
.198 .198
4.050 1 .044
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
20.
b.
83
Gastropati HT Porta * Survival rate
Crosstab
5 34 39
7.7 31.3 39.0
8.3% 14.0% 12.9%
1.7% 11.2% 12.9%
55 209 264
52.3 211.7 264.0
91.7% 86.0% 87.1%
18.2% 69.0% 87.1%
60 243 303
60.0 243.0 303.0
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Count
Expected Count
% within Surv ival rate
% of Total
Ya
Tidak
Gastropati
HT Porta
Total
Meninggal Hidup
Surv ival rate
Total
Chi-Square Tests
1.374b 1 .241
.916 1 .339
1.503 1 .220
.288 .170
1.369 1 .242
303
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 7.
72.
b.
84
Ensefalopati * Survival rate Crosstabulation
5 27 32
12.5% 84.4% 44.4%
6.9% 37.5% 44.4%
35 5 40
87.5% 15.6% 55.6%
48.6% 6.9% 55.6%
40 32 72
100.0% 100.0% 100.0%
55.6% 44.4% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
grade I-II
grade III-IV
Ensef alopati
Total
Meninggal Hidup
Surv iv al rate
Total
Ascites * Survival rate Crosstabulation
36 143 179
76.6% 81.3% 80.3%
16.1% 64.1% 80.3%
11 33 44
23.4% 18.8% 19.7%
4.9% 14.8% 19.7%
47 176 223
100.0% 100.0% 100.0%
21.1% 78.9% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
ringan-sedang
berat
Ascites
Total
Meninggal Hidup
Surv ival rate
Total
85
Klasifikasi CHILD-PUGH * Survival rate
Tahun * Survival rate Crosstabulation
22 90 112
36.7% 37.0% 37.0%
7.3% 29.7% 37.0%
22 101 123
36.7% 41.6% 40.6%
7.3% 33.3% 40.6%
16 52 68
26.7% 21.4% 22.4%
5.3% 17.2% 22.4%
60 243 303
100.0% 100.0% 100.0%
19.8% 80.2% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
2010
2011
2012
Tahun
Total
Meninggal Hidup
Surv ival rate
Total
Crosstab
0 15 15
.0% 8.2% 6.4%
.0% 6.4% 6.4%
4 71 75
7.7% 39.0% 32.1%
1.7% 30.3% 32.1%
48 96 144
92.3% 52.7% 61.5%
20.5% 41.0% 61.5%
52 182 234
100.0% 100.0% 100.0%
22.2% 77.8% 100.0%
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
Count
% within Surv ival rate
% of Total
A
B
C
Klasif ikasi
CHILD-PUGH
Total
Meninggal Hidup
Surv iv al rate
Total
86
Chi-Square Tests
26.949a 2 .000
33.354 2 .000
24.502 1 .000
234
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asy mp. Sig.
(2-sided)
1 cells (16.7%) have expected count less than 5. The
minimum expected count is 3.33.
a.
87
Lampiran 3. Tabel Frekuensi dari beberapa Variabel
Variabel Frekuensi Prosentase
Jenis kelamin
Laki-laki 205 67,7
Perempuan 98 32,3
Usia
< 31 tahun 10 3,3
31 – 40 tahun 21 6,9
41 – 50 tahun 79 26,1
51 – 60 tahun 104 34,3
61 – 70 tahun 59 19,5
> 70 tahun 30 9,9
Keluhan utama
Perut membesar 111 36,4
Nyeri perut 17 5,6
Berak darah 32 10,5
Muntah darah 63 20,7
Badan lemas 15 4,9
Penurunan kesadaran 18 5,9
Mata kuning 13 4,3
Lain2 48 15,7
Etiologi
Virus
HBV 184 60,7
HCV 55 18,2
HBV dan HCV 17 30,9
Non Virus
NAFL 21 6,9
Lain-lain 59 19,5
Klasifikasi CHILD-PUGH
A 15 6,4
B 75 32,1
C 144 61,5
Komplikasi
Perdarahan varises esophagus 59 19,5
88
Ensefalopati Hepatikum 66 21,8
Karsinoma hepatoseluler 34 11,2
Sindrom hepatorenal 5 1,7
Hematemesis 79 26,1
Melena 85 28,1
Ascites 224 73,9
Peritonitis bacterial spontan 1 0,3
Gastropati HT Porta 29 12,9
Komorbid
Efusi pleura 38 12,5
Pneumonia 37 12,2
TB paru 5 1,7
Syok 7 2,3
Sepsis 19 6,3
Penyakit ginjal 10 3,3
Penyakit jantung 3 1
Ensefalopati Hepatikum
Tidak ada 233 76,4
Grade I-II 32 10,5
Grade III-IV 40 13,1
Ascites
Tidak ada 81 26,6
Ringan-sedang 180 59
Berat 44 14,4
Survival rate
Meninggal 60 19,8
Hidup 243 80,2
89
Lampiran 4. Tabel Tabulasi Silang Berdasarkan Survival Rate
Variabel
Status
Meninggal Hidup Jumlah
n % n % n %
Jenis kelamin
Laki-laki 39 65 166 68,3 205 67,7
Perempuan 21 35 77 31,7 98 32,3
Usia
< 31 tahun 1 1,7 9 3,7 10 3,3
31 – 40 tahun 3 5 18 7,4 21 6,9
41 – 50 tahun 15 25 64 26,3 79 26,1
51 – 60 tahun 19 31,7 85 35 104 34,3
61 – 70 tahun 15 25 44 18,1 59 19,5
> 70 tahun 7 11,7 23 9,5 30 9,9
Etiologi
Virus
HBV 35 58,3 149 61,3 184 60,7
HCV 8 13,3 47 19,3 55 18,2
HBV dan HCV 4 50 13 27,7 17 30,9
Non Virus
NAFL 3 5 18 7,4 21 6,9
Lain-lain 18 30 41 16,9 59 19,5
Klasifikasi CHILD-PUGH
A 0 0 15 8,2 15 6,4
B 4 7,7 71 39 75 32,1
C 48 92,3 96 52,7 144 61,5
Komplikasi
Perdarahan varises esophagus 7 11,7 52 21,4 59 19,5
Ensefalopati hepatikum 41 68,3 25 10,3 66 21,8
Karsinoma hepatoseluler 5 8,3 29 11,9 34 11,2
Sindroma hepatorenal 2 3,3 3 1,2 5 1,7
Hematemesis 17 28,3 62 25,5 79 26,1
Melena 18 30 67 27,6 85 28,1
Ascites 47 78,3 177 72,8 224 73,9
90
Peritonitis bakterial spontan 1 1,7 0 0 1 0,3
Gastropati HT Porta 5 8,3 34 14 39 12,9
Komorbid
Efusi pleura 3 5 35 14,4 38 12,5
Pneumonia 15 25 22 9,1 37 12,2
TB paru 0 0 5 2,1 5 1,7
Syok 7 11,7 0 0 7 2,3
Sepsis 18 30 1 0,4 19 6,3
Penyakit ginjal 4 6,7 6 2,5 10 3,3
Penyakit jantung 0 0 3 1,2 3 1
Ensefalopati Hepatikum
Grade I-II 5 12,5 27 84,4 32 44,4
Grade III-IV 35 87,5 5 15,6 40 55,6
Ascites
Ringan-sedang 36 76,6 143 81,3 179 80,3
Berat 11 23,4 33 18,8 44 19,7
Tahun
2010 22 36,7 90 37 112 37
2011 22 36,7 101 41,6 123 40,6
2012 16 26,7 52 21,4 68 22,4
91
Tabel uji normalitas kolmogorov smirnov
Variabel p
Usia 0,193
Bilirubin Total 0,000
Albumin serum 0,246
PPT 0,000
Lama perawatan 0,000
Tabel deskriptif
Variabel N Mean SD
Usia 303 54,17 11,755
Albumin serum 259 2,345 0,6009
Variabel N Median Min. Max.
Bilirubin Total 245 1,98 0,11 36,31
PPT 226 5,3 -0,9 106,3
Lama perawatan 303 9 0 48
Tabel Chi Square Klasifikasi CHILD-PUGH terhadap Survival rate
92
Klasifikasi
CHILD-PUGH
Status
p Meninggal Hidup Jumlah
n % n % n %
A 0 0 15 8,2 15 6,4 < 0,001
B 4 7,7 71 39 75 32,1
C 48 92,3 96 52,7 144 61,5
Dari uji Chi Square antara Klasifikasi CHILD-PUGH terhadap status survival
didapatkan nilai p = < 0,001, karena p < 0,05 maka dapat disimpulkan terdapat
hubungan yang signifikan antara klasifikasi CHILD-PUGH dengan status survival.
93
Tabel sebaran usia berdasarkan survival rate
Usia
Survival Rate
p Meninggal Hidup
n (60) % n (243) %
< 31 1 1,7 9 3,7 0,761£
31 – 40 3 5 18 7,4
41 – 50 15 25 64 26,3
51 – 60 19 31,7 85 35
61 – 70 15 25 44 18,1
> 70 7 11,7 23 9,5
Keterangan :
£ Pearson Chi Square
Tabel Hubungan comorbid terhadap survival rate
Comorbid
Survival Rate
p Meninggal Hidup
n (60) % n (243) %
Efusi pleura 3 5 35 14,4 0,049*£
Pneumonia 15 25 22 9,1 0,001*£
TB paru 0 0 5 2,1 0,587¥
Syok 7 11,7 0 0 0,000*¥
Sepsis 18 30 1 0,4 0,000*¥
Penyakit ginjal 4 6,7 6 2,5 0,114¥
Penyakit jantung 0 0 3 1,2 1,000¥
Keterangan :
* Signifikan p < 0,05
£ Pearson Chi Square
94
¥ Fisher’s Exact Test
Tabel Hubungan komplikasi terhadap survival rate
Komplikasi
Survival Rate
p Meninggal Hidup
n (60) % n (243) %
Perdarahan varises Esofagus 7 11,7 52 21,4 0,088£
Ensefalopati Hepatikum 41 68,3 25 10,3 0,001*£
Karsinoma Hepatoseluler 5 8,3 29 11,9 0,429£
Sindroma Hepatorenal 2 3,3 3 1,2 0,258¥
Hematemesis 17 28,3 62 25,5 0,656£
Melena 18 30 67 27,6 0,708£
Ascites 47 78,3 177 72,8 0,385£
Peritonitis bacterial spontan 1 1,7 0 0 0,198¥
Gastropati HT Porta 5 8,3 34 14 0,241£
Keterangan :
* Signifikan p < 0,05
£ Pearson Chi Square
¥ Fisher’s Exact Test
95
Lampiran 5. Ethical Clearance
96
Lampiran 6. Surat Permohonan Peminjaman Rekam Medis
97
Lampiran 7. Dokumentasi Penelitian
98
Lampiran 8. Biodata Mahasiswa
Identitas
Nama : Ni Made Tuty Marselina
NIM : 22010110110031
Tempat / tanggal lahir : Denpasar, 23 Maret 1992
Jenis Kelamin : Perempuan
Alamat : Jl. Tanah Putih II No.8 RT03 RW02, Semarang
Nomor HP : 085737105588
E-mail : tuty.marselina@rocketmail.com
Riwayat Pendidikan Formal
1. SD : 1998 Lulus tahun : 2004
2. SMP : 2004 Lulus tahun : 2007
3. SMA : 2007 Lulus tahun : 2010
4. FK UNDIP : Masuk tahun 2010
Recommended